Article ; Online: Metabolic engineering of probiotic Escherichia coli for cytolytic therapy of tumors.
2021 Volume 11, Issue 1, Page(s) 5853
Abstract: Bacterial cancer therapy was developed using probiotic Escherichia coli Nissle 1917 (EcN) for medical intervention of colorectal cancer. EcN was armed with HlyE, a small cytotoxic protein, under the control of the araBAD promoter ( ... ...
Abstract | Bacterial cancer therapy was developed using probiotic Escherichia coli Nissle 1917 (EcN) for medical intervention of colorectal cancer. EcN was armed with HlyE, a small cytotoxic protein, under the control of the araBAD promoter (P |
---|---|
MeSH term(s) | Animals ; Cell Death ; Cell Line, Tumor ; Escherichia coli/metabolism ; Escherichia coli Proteins/metabolism ; Genetic Vectors/metabolism ; Hemolysin Proteins/metabolism ; Immunity ; Male ; Metabolic Engineering ; Mice, Inbred BALB C ; Mice, Nude ; Neoplasms/immunology ; Neoplasms/pathology ; Neoplasms/therapy ; Probiotics/metabolism ; Mice |
Chemical Substances | Escherichia coli Proteins ; Hemolysin Proteins ; hlyE protein, E coli |
Language | English |
Publishing date | 2021-03-12 |
Publishing country | England |
Document type | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2615211-3 |
ISSN | 2045-2322 ; 2045-2322 |
ISSN (online) | 2045-2322 |
ISSN | 2045-2322 |
DOI | 10.1038/s41598-021-85372-6 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.